<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2007-8064</journal-id>
<journal-title><![CDATA[Entreciencias: diálogos en la sociedad del conocimiento]]></journal-title>
<abbrev-journal-title><![CDATA[Entreciencias: diálogos soc. conoc.]]></abbrev-journal-title>
<issn>2007-8064</issn>
<publisher>
<publisher-name><![CDATA[Universidad Nacional Autónoma de México, Escuela Nacional de Estudios Superiores]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2007-80642024000100205</article-id>
<article-id pub-id-type="doi">10.22201/enesl.20078064e.2024.26.87497</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Desafíos de la investigación nanomédica en México]]></article-title>
<article-title xml:lang="en"><![CDATA[Challenges of nanomedical research in Mexico]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Soto Vázquez]]></surname>
<given-names><![CDATA[Roberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Foladori]]></surname>
<given-names><![CDATA[Guillermo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Záyago Lau]]></surname>
<given-names><![CDATA[Edgar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Autónoma de Zacatecas  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2024</year>
</pub-date>
<volume>12</volume>
<numero>26</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2007-80642024000100205&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2007-80642024000100205&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2007-80642024000100205&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo:  Identificar los desafíos que enfrenta la investigación en nanomedicina en México según la opinión de expertos en la materia.  Diseño metodológico:  Se realizaron entrevistas semiestructuradas a investigadores mexicanos del área de nanomedicina. Los entrevistados fueron seleccionados a través de un muestreo intencional. Las entrevistas se llevaron a cabo de manera presencial y a distancia. El procesamiento de la información se realizó con el software ATLAS.ti.  Resultados:  Se identificaron desafíos en distintos rubros: financiamiento, beneficio social, recursos humanos, infraestructura, nanotoxicología, patentamiento, investigación preclínica y clínica, vinculación academia-industria, regulación, política científica y trabajo multidisciplinario.  Limitaciones de la investigación:  Las entrevistas se realizaron únicamente a investigadores. Sería necesario entrevistar a otros agentes involucrados en la cadena de valor de la nanomedicina tales como empresarios y funcionarios del sector salud.  Hallazgos:  Los principales desafíos que enfrenta la investigación nanomédica en México son el financiamiento reducido, investigaciones con poca incidencia en la sociedad, inexistencia de programas educativos específicos en nanomedicina, escaso patentamiento, nula vinculación con empresas y falta de regulación. Algunas propuestas para encarar estos desafíos se analizan en el presente trabajo.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Purpose:  To identify the challenges faced by nanomedicine in Mexico, according to the opinion of experts in the field.  Methodological design:  Semi-structured interviews were conducted with Mexican researchers in the field of nanomedicine. The participants were selected through purposive sampling. Interviews were both online and face-to-face. The information was processed with ATLAS.ti software.  Results:  Challenges were identified in different areas: financing, social benefit, human resources, infrastructure, nanotoxicology, patenting, preclinical and clinical research, academia-industry linkage, regulation, scientific policy and multidisciplinary work.  Research limitations:  Interviews included researchers only. It would be necessary to interview other agents involved in the nanomedicine chain of value, such as entrepreneurs and health sector managers.  Findings:  The main challenges facing nanomedical research in Mexico are the following: reduced funding, research with little impact on society, lack of specific educational programs in nanomedicine, low patenting activity, weak links between academia and industry, and lack of regulation. Some proposals to address these challenges are analyzed in this paper.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[nanomedicina]]></kwd>
<kwd lng="es"><![CDATA[nanotecnología]]></kwd>
<kwd lng="es"><![CDATA[investigación y desarrollo (I+D)]]></kwd>
<kwd lng="es"><![CDATA[entrevistas]]></kwd>
<kwd lng="en"><![CDATA[nanomedicine]]></kwd>
<kwd lng="en"><![CDATA[nanotechnology]]></kwd>
<kwd lng="en"><![CDATA[research and development (R&amp;D)]]></kwd>
<kwd lng="en"><![CDATA[interviews]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Agrawal]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Doxorubicin]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Enna]]></surname>
<given-names><![CDATA[S.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Bylund]]></surname>
<given-names><![CDATA[D.B.]]></given-names>
</name>
</person-group>
<source><![CDATA[xPharm: the comprehensive pharmacology reference]]></source>
<year>2008</year>
<page-range>1-5</page-range><publisher-loc><![CDATA[Amsterdam ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Allhoff]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk, precaution, and emerging technologies]]></article-title>
<source><![CDATA[Studies in Ethics, Law, and Technology]]></source>
<year>2009</year>
<volume>3</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Archibald]]></surname>
<given-names><![CDATA[M. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ambagtsheer]]></surname>
<given-names><![CDATA[R. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Casey]]></surname>
<given-names><![CDATA[M. G.]]></given-names>
</name>
<name>
<surname><![CDATA[Lawless]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Using zoom videoconferencing for qualitative data collection: Perceptions and experiences of researchers and participants]]></article-title>
<source><![CDATA[International Journal of Qualitative Methods]]></source>
<year>2019</year>
<volume>18</volume>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arentshorst]]></surname>
<given-names><![CDATA[M. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Buning]]></surname>
<given-names><![CDATA[T.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Boon]]></surname>
<given-names><![CDATA[W. P. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Broerse]]></surname>
<given-names><![CDATA[J. E. W.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prospecting responsible technology paths: Management options for an appropriate societal embedding of medical neuroimaging]]></article-title>
<source><![CDATA[Science and Public Policy]]></source>
<year>2015</year>
<volume>42</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>775-88</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aronson]]></surname>
<given-names><![CDATA[J. K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Paclitaxel]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Aronson]]></surname>
<given-names><![CDATA[J. K.]]></given-names>
</name>
</person-group>
<source><![CDATA[Meyler&#8217;s side effects of drugs]]></source>
<year>2016</year>
<edition>16</edition>
<page-range>445-52</page-range><publisher-loc><![CDATA[Amsterdam ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Battard]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Convergence and multidisciplinarity in nanotechnology: Laboratories as technological hubs]]></article-title>
<source><![CDATA[Technovation]]></source>
<year>2012</year>
<volume>32</volume>
<numero>3-4</numero>
<issue>3-4</issue>
<page-range>234-44</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bracamonte-Arámburo]]></surname>
<given-names><![CDATA[E. Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Foladori]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efectos adversos de mascarillas protectoras contra la COVID-19: casos conflictivos]]></article-title>
<source><![CDATA[Investigación y Ciencia de la Universidad Autónoma de Aguascalientes]]></source>
<year>2022</year>
<volume>30</volume>
<numero>85</numero>
<issue>85</issue>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[E. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Harford]]></surname>
<given-names><![CDATA[J. B.]]></given-names>
</name>
<name>
<surname><![CDATA[Eaton]]></surname>
<given-names><![CDATA[M. A. W.]]></given-names>
</name>
<name>
<surname><![CDATA[Boisseau]]></surname>
<given-names><![CDATA[P. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Dube]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Hayeshi]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Swai]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[D. S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanomedicine: Past, present and future - A global perspective]]></article-title>
<source><![CDATA[Biochemical and Biophysical Research Communications]]></source>
<year>2015</year>
<volume>468</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>511-7</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cozzens]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Emerging technologies and inequalities: Beyond the technological transition]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Parker]]></surname>
<given-names><![CDATA[R. A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Can emerging technologies make a difference in development?]]></source>
<year>2012</year>
<page-range>1-11</page-range><publisher-loc><![CDATA[Oxford ]]></publisher-loc>
<publisher-name><![CDATA[Routledge]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[DeJonckheere]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Vaughn]]></surname>
<given-names><![CDATA[L. M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Semistructured interviewing in primary care research: A balance of relationship and rigour]]></article-title>
<source><![CDATA[Family Medicine and Community Health]]></source>
<year>2019</year>
<volume>7</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Domingues]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Alvarez-Lorenzo]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Concheiro]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Jarak]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Veiga]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Barbosa]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Dourado]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Figueiras]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Where is nano today and where is it headed? A review of nanomedicine and the dilemma of nanotoxicology]]></article-title>
<source><![CDATA[ACS Nano]]></source>
<year>2022</year>
<volume>16</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>9994-10041</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Foladori]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanotecnología, salud y pobreza. ¿Cuáles son las expectativas?]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Coca]]></surname>
<given-names><![CDATA[J. R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Varia biológica: filosofia ciencia y tecnología]]></source>
<year>2007</year>
<page-range>43-63</page-range><publisher-loc><![CDATA[León, España ]]></publisher-loc>
<publisher-name><![CDATA[Universidad de León, Centro de Estudios Metodológicos e Interdisciplinares]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Foladori]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Principio de precaución y análisis de riesgo regulatorio: dos fuerzas sociales encontradas y ejemplificadas en el caso de las nanotecnologías]]></article-title>
<source><![CDATA[Trilogía: Ciencia Tecnología Sociedad]]></source>
<year>2022</year>
<volume>14</volume>
<numero>26</numero>
<issue>26</issue>
</nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Foladori]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Invernizzi]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[AgNano, the construction of occupational health standards: A Status Update]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Pathak]]></surname>
<given-names><![CDATA[C.S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Silver micro-nanoparticles-properties, synthesis, characterization, and applications]]></source>
<year>2021</year>
<page-range>141-62</page-range><publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[IntechOpen]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Granados]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Joly]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chapter 7-Intellectual property and innovation in translational medicine]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Wehling]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Principles of translational science in medicine]]></source>
<year>2015</year>
<edition>2</edition>
<page-range>281-97</page-range><publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Academic Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Graur]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Elisei]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Szasz]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Neagos]]></surname>
<given-names><![CDATA[H. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Muresan]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Furcea]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Neagoe]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Diudea]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ethical issues in nanomedicine]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Vlad]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Ciupa]]></surname>
<given-names><![CDATA[R. V.]]></given-names>
</name>
</person-group>
<source><![CDATA[International Conference on Advancements of Medicine and Health Care through Technology]]></source>
<year>2011</year>
<page-range>9-12</page-range><publisher-loc><![CDATA[Berlin ]]></publisher-loc>
<publisher-name><![CDATA[Springer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gray]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Wong-Wylie]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Rempel]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Cook]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Expanding qualitative research interviewing strategies: Zoom video communications]]></article-title>
<source><![CDATA[Qualitative Report]]></source>
<year>2020</year>
<volume>25</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1292-301</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hemmerich]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Ecker]]></surname>
<given-names><![CDATA[G. F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[In silico toxicology: From structure-activity relationships towards deep learning and adverse outcome pathways]]></article-title>
<source><![CDATA[WIREs Computational Molecular Science]]></source>
<year>2020</year>
<volume>10</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanomedicina: La nanomedicina tiene un alto potencial económico y podría reescribir completamente el mercado farmacéutico mundial]]></article-title>
<source><![CDATA[Notas INCyTU]]></source>
<year>2019</year>
<numero>32</numero>
<issue>32</issue>
</nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="">
<collab>Instituto Nacional de Estadística y Geografía [Inegi]</collab>
<source><![CDATA[Estadística de defunciones registradas de enero a junio de 2022 (preliminar)]]></source>
<year>2023</year>
</nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jackman]]></surname>
<given-names><![CDATA[J. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Cho]]></surname>
<given-names><![CDATA[D.-J.]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[J. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Besenbacher]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Bonnell]]></surname>
<given-names><![CDATA[D. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Hersam]]></surname>
<given-names><![CDATA[M. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Cho]]></surname>
<given-names><![CDATA[N.-J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanotechnology education for the global world: Training the leaders of tomorrow]]></article-title>
<source><![CDATA[ACS Nano]]></source>
<year>2016</year>
<volume>10</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>5595-9</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of science in the policy subsystem: An application of the advocacy coalition framework to nanotechnology regulation policies]]></article-title>
<source><![CDATA[International Journal of Public Administration]]></source>
<year>2022</year>
<volume>47</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>397-414</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Corley]]></surname>
<given-names><![CDATA[E. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Scheufele]]></surname>
<given-names><![CDATA[D. A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanoscientists and political involvement: Which characteristics make scientists more likely to support engagement in political debates?]]></article-title>
<source><![CDATA[Science and Public Policy]]></source>
<year>2017</year>
<volume>44</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>317-27</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lama]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Merlin-Zhang]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[In vitro and in vivo models for evaluating the oral toxicity of nanomedicines]]></article-title>
<source><![CDATA[Nanomaterials]]></source>
<year>2020</year>
<volume>10</volume>
<numero>11</numero>
<issue>11</issue>
</nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lame]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Systematic literature reviews: An introduction]]></article-title>
<source><![CDATA[Proceedings of the Design Society: International Conference on Engineering Design]]></source>
<year>2019</year>
<volume>1</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1633-42</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lammers]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Ferrari]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The success of nanomedicine]]></article-title>
<source><![CDATA[Nano Today]]></source>
<year>2020</year>
<volume>31</volume>
</nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leist]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Hasiwa]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Daneshian]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Hartung]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validation and quality control of replacement alternatives - current status and future challenges]]></article-title>
<source><![CDATA[Toxicology Research]]></source>
<year>2012</year>
<volume>1</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>8-22</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Webster]]></surname>
<given-names><![CDATA[T. J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chapter 1-Trends in nanomedicine]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Webster]]></surname>
<given-names><![CDATA[T. J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nanomedicine]]></source>
<year>2023</year>
<edition>2</edition>
<page-range>1-18</page-range><publisher-loc><![CDATA[Sawston, Cambridge, UK ]]></publisher-loc>
<publisher-name><![CDATA[Woodhead]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[Q.]]></given-names>
</name>
<name>
<surname><![CDATA[Zou]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[He]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Current research trends of nanomedicines]]></article-title>
<source><![CDATA[Acta Pharmaceutica Sinica B]]></source>
<year>2023</year>
<volume>13</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>4391-416</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lopezosa]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Codina]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Freixa]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<source><![CDATA[ATLAS.ti para entrevistas semiestructuradas: Guía de uso para un análisis cualitativo eficaz]]></source>
<year>2022</year>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Pompeu Fabra]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lund]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The questionnaire method in systems research: An overview of sample sizes, response rates and statistical approaches utilized in survey studies]]></article-title>
<source><![CDATA[VINE Journal of Information and Knowledge Management Systems]]></source>
<year>2023</year>
<volume>53</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lysaght]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Kerridge]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rhetoric, power and legitimacy: A critical analysis of the public policy disputes surrounding stem cell research in Australia (2005-6)]]></article-title>
<source><![CDATA[Public Understanding of Science]]></source>
<year>2012</year>
<volume>21</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>195-210</page-range></nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maji]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Mahajan]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Sriram]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Mehra]]></surname>
<given-names><![CDATA[N. K.]]></given-names>
</name>
<name>
<surname><![CDATA[Srivastava]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Madan]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[S. B.]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[P. K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chapter 18 - Nanotoxicology: Toxicity and safety issues of nanoparticles]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Mehra]]></surname>
<given-names><![CDATA[N. K.]]></given-names>
</name>
<name>
<surname><![CDATA[Srivastava]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Madan]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[P. Kumar]]></given-names>
</name>
</person-group>
<source><![CDATA[Multifunctional nanocarriers]]></source>
<year>2022</year>
<page-range>461-74</page-range><publisher-loc><![CDATA[Amsterdam ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malva]]></surname>
<given-names><![CDATA[A. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Kelchtermans]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Leten]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Veugelers]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Basic science as a prescription for breakthrough inventions in the pharmaceutical industry]]></article-title>
<source><![CDATA[The Journal of Technology Transfer]]></source>
<year>2015</year>
<volume>40</volume>
<page-range>670-95</page-range></nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martins]]></surname>
<given-names><![CDATA[J. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Neves]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[de la Fuente]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Celia]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Florindo]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Günday-Türeli]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Popat]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[H. A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The solid progress of nanomedicine]]></article-title>
<source><![CDATA[Drug Delivery and Translational Research]]></source>
<year>2020</year>
<volume>10</volume>
<page-range>726-9</page-range></nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Merck]]></surname>
<given-names><![CDATA[A. W.]]></given-names>
</name>
<name>
<surname><![CDATA[Grieger]]></surname>
<given-names><![CDATA[K. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Kuzma]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[How can we promote the responsible innovation of nano-agrifood research?]]></article-title>
<source><![CDATA[Environmental Science &amp; Policy]]></source>
<year>2022</year>
<volume>137</volume>
<page-range>185-90</page-range></nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Millán-Chiu]]></surname>
<given-names><![CDATA[B. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Rodriguez-Torres]]></surname>
<given-names><![CDATA[M. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Loske]]></surname>
<given-names><![CDATA[A. M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanotoxicology in plants]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Patra]]></surname>
<given-names><![CDATA[J. K.]]></given-names>
</name>
<name>
<surname><![CDATA[Fraceto]]></surname>
<given-names><![CDATA[L. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Das]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Campos]]></surname>
<given-names><![CDATA[E. V. R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Green nanoparticles: Synthesis and biomedical applications]]></source>
<year>2020</year>
<page-range>43-76</page-range><publisher-loc><![CDATA[Cham ]]></publisher-loc>
<publisher-name><![CDATA[Springer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oliffe]]></surname>
<given-names><![CDATA[J. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Kelly]]></surname>
<given-names><![CDATA[M. T.]]></given-names>
</name>
<name>
<surname><![CDATA[Gonzalez]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[W. F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Zoom interviews: Benefits and concessions]]></article-title>
<source><![CDATA[International Journal of Qualitative Methods]]></source>
<year>2021</year>
<volume>20</volume>
</nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="book">
<collab>Organisation for Economic Co-operation and Development [OECD]</collab>
<source><![CDATA[Scientific advice for policy making: The role and responsibility of expert bodies and individual scientists]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Paris ]]></publisher-loc>
<publisher-name><![CDATA[OECD]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ortiz]]></surname>
<given-names><![CDATA[Á.]]></given-names>
</name>
<name>
<surname><![CDATA[Foladori]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Bracamonte]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Elementos críticos sobre las nanotecnologías en México]]></article-title>
<source><![CDATA[Espacio I+D, Innovación más desarrollo]]></source>
<year>2022</year>
<volume>11</volume>
<numero>31</numero>
<issue>31</issue>
</nlm-citation>
</ref>
<ref id="B41">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quezada-Ramírez]]></surname>
<given-names><![CDATA[M. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Chin-Chan]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Poor investment and limited research positions in biomedical research: Challenges for young researchers in Mexico]]></article-title>
<source><![CDATA[Health Policy and Technology]]></source>
<year>2021</year>
<volume>10</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B42">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rotolo]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Hicks]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[B. R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[What is an emerging technology?]]></article-title>
<source><![CDATA[Research Policy]]></source>
<year>2015</year>
<volume>44</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1827-43</page-range></nlm-citation>
</ref>
<ref id="B43">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Røttingen]]></surname>
<given-names><![CDATA[J.-A.]]></given-names>
</name>
<name>
<surname><![CDATA[Regmi]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Eide]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[A. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Viergever]]></surname>
<given-names><![CDATA[R. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Årdal]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Guzman]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Terry]]></surname>
<given-names><![CDATA[R. F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mapping of available health research and development data: What&#8217;s there, what&#8217;s missing, and what role is there for a global observatory?]]></article-title>
<source><![CDATA[The Lancet]]></source>
<year>2013</year>
<volume>382</volume>
<numero>9900</numero>
<issue>9900</issue>
<page-range>1286-307</page-range></nlm-citation>
</ref>
<ref id="B44">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saldívar]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recomendaciones de política pública de nanociencia y nanotecnología en México: Privilegiar el bienestar humano y ambiental]]></article-title>
<source><![CDATA[Mundo Nano. Revista Interdisciplinaria en Nanociencias y Nanotecnología]]></source>
<year>2022</year>
<volume>15</volume>
<numero>28</numero>
<issue>28</issue>
<page-range>1e-23e</page-range></nlm-citation>
</ref>
<ref id="B45">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Salter]]></surname>
<given-names><![CDATA[A. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[B. R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The economic benefits of publicly funded basic research: A critical review]]></article-title>
<source><![CDATA[Research Policy]]></source>
<year>2001</year>
<volume>30</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>509-32</page-range></nlm-citation>
</ref>
<ref id="B46">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sayes]]></surname>
<given-names><![CDATA[C. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Child]]></surname>
<given-names><![CDATA[J. R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chapter 1.4 - Nanotoxicology: Determining nano-bio interactions and evaluating toxicity using in vitro models]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Dolez]]></surname>
<given-names><![CDATA[P. I.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nanoengineering]]></source>
<year>2015</year>
<page-range>85-110</page-range><publisher-loc><![CDATA[Amsterdam ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B47">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Seyhan]]></surname>
<given-names><![CDATA[A. A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lost in translation: The valley of death across preclinical and clinical divide - identification of problems and overcoming obstacles]]></article-title>
<source><![CDATA[Translational Medicine Communications]]></source>
<year>2019</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B48">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soto Vázquez]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Análisis de la investigación y desarrollo de la nanomedicina en México]]></source>
<year>2023</year>
</nlm-citation>
</ref>
<ref id="B49">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soto Vázquez]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La nanomedicina en México: un análisis de las actividades de investigación y desarrollo]]></article-title>
<source><![CDATA[Avance y Perspectiva]]></source>
<year>2023</year>
<volume>9</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B50">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soto Vázquéz]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Foladori]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La nanomedicina en México desde el punto de vista de los investigadores]]></article-title>
<source><![CDATA[Temas de Ciencia y Tecnología]]></source>
<year>2023</year>
<volume>27</volume>
<numero>80</numero>
<issue>80</issue>
<page-range>55-8</page-range></nlm-citation>
</ref>
<ref id="B51">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soto Vázquéz]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Záyago]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Maldonado]]></surname>
<given-names><![CDATA[L. A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanomedicina para enfrentar la pandemia de COVID-19: un análisis bibliométrico de las publicaciones de Web of Science con la herramienta Bibliometrix de R]]></article-title>
<source><![CDATA[Revista Cubana de Información en Ciencias de la Salud]]></source>
<year>2022</year>
<volume>33</volume>
</nlm-citation>
</ref>
<ref id="B52">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Su]]></surname>
<given-names><![CDATA[L. Y.-F.]]></given-names>
</name>
<name>
<surname><![CDATA[Cacciatore]]></surname>
<given-names><![CDATA[M. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Brossard]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Corley]]></surname>
<given-names><![CDATA[E. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Scheufele]]></surname>
<given-names><![CDATA[D. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Xenos]]></surname>
<given-names><![CDATA[M. A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Attitudinal gaps: How experts and lay audiences form policy attitudes toward controversial science]]></article-title>
<source><![CDATA[Science and Public Policy]]></source>
<year>2016</year>
<volume>43</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>196-206</page-range></nlm-citation>
</ref>
<ref id="B53">
<nlm-citation citation-type="">
<collab>Subsecretaría de Educación Superior</collab>
<source><![CDATA[Instituciones de Educación Superior]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B54">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vega-González]]></surname>
<given-names><![CDATA[L. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández-Jardines]]></surname>
<given-names><![CDATA[I. J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The costs of patenting in Mexico]]></article-title>
<source><![CDATA[Revista Médica Del Hospital General de México]]></source>
<year>2018</year>
<volume>81</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>165-76</page-range></nlm-citation>
</ref>
<ref id="B55">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[von Ranke]]></surname>
<given-names><![CDATA[N. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Geraldo]]></surname>
<given-names><![CDATA[R. B.]]></given-names>
</name>
<name>
<surname><![CDATA[Lima]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Evangelho]]></surname>
<given-names><![CDATA[V. G. O.]]></given-names>
</name>
<name>
<surname><![CDATA[Flammini]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Cabral]]></surname>
<given-names><![CDATA[L. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Castro]]></surname>
<given-names><![CDATA[H. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Rodrigues]]></surname>
<given-names><![CDATA[C. R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Applying in silico approaches to nanotoxicology: Current status and future potential]]></article-title>
<source><![CDATA[Computational Toxicology]]></source>
<year>2022</year>
<volume>22</volume>
</nlm-citation>
</ref>
<ref id="B56">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Von Schomberg]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prospects for technology assessment in a framework of responsible research and innovation]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Dusseldorp]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Beecroft]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Technikfolgen abschätzen lehren: Bildungspotenziale transdisziplinärer Methoden]]></source>
<year>2011</year>
<page-range>1-19</page-range><publisher-loc><![CDATA[Wiesbaden ]]></publisher-loc>
<publisher-name><![CDATA[Vs Verlag]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B57">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Woodson]]></surname>
<given-names><![CDATA[T. S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Public private partnerships and emerging technologies: A look at nanomedicine for diseases of poverty]]></article-title>
<source><![CDATA[Research Policy]]></source>
<year>2016</year>
<volume>45</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1410-8</page-range></nlm-citation>
</ref>
<ref id="B58">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wright]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Finn]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Gellert]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Gutwirth]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Schütz]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Friedew]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Venier]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Mordini]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ethical dilemma scenarios and emerging technologies]]></article-title>
<source><![CDATA[Technological Forecasting and Social Change]]></source>
<year>2014</year>
<volume>87</volume>
<page-range>325-36</page-range></nlm-citation>
</ref>
<ref id="B59">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[L.-P.]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Grand challenges in nanomedicine]]></article-title>
<source><![CDATA[Materials Science and Engineering: C]]></source>
<year>2020</year>
<volume>106</volume>
</nlm-citation>
</ref>
<ref id="B60">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Merlin]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Challenges to safe nanomedicine treatment]]></article-title>
<source><![CDATA[Nanomaterials]]></source>
<year>2023</year>
<volume>13</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
<ref id="B61">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Younis]]></surname>
<given-names><![CDATA[M. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Tawfeek]]></surname>
<given-names><![CDATA[H. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Abdellatif]]></surname>
<given-names><![CDATA[A. A. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Abdel-Aleem]]></surname>
<given-names><![CDATA[J. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Harashima]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical translation of nanomedicines: Challenges, opportunities, and keys]]></article-title>
<source><![CDATA[Advanced Drug Delivery Reviews]]></source>
<year>2022</year>
<volume>181</volume>
</nlm-citation>
</ref>
<ref id="B62">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Youtie]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Porter]]></surname>
<given-names><![CDATA[A. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Ying]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Early social science research about Big Data]]></article-title>
<source><![CDATA[Science and Public Policy]]></source>
<year>2017</year>
<volume>44</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>65-74</page-range></nlm-citation>
</ref>
<ref id="B63">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Yan]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[X.]]></given-names>
</name>
<name>
<surname><![CDATA[Zhu]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Gu]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Progress, challenges, and future of nanomedicine]]></article-title>
<source><![CDATA[Nano Today]]></source>
<year>2020</year>
<volume>35</volume>
</nlm-citation>
</ref>
<ref id="B64">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[America is running low on a crucial resource for COVID-19 vaccines: The country is facing a monkey shortage]]></source>
<year>2020</year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
